Biotech Snap
Login
Subscribe
Biotech Snap
Archive
Page 1
Latest news
13 hours ago
Pfizer signs a $530M vaccine deal & Novo drops another cell therapy
Joachim Eeckhout, +1
Jan 21, 2026
GSK buys a food allergy biotech for $2.2B & Exciva raises €51M to fight Alzheimer’s agitation symptoms
Joachim Eeckhout, +1
Jan 20, 2026
SpyGlass and Agomab plan an IPO & Genmab fails a Phase 3
Joachim Eeckhout, +1
Jan 16, 2026
Vor Bio changes its priorities & Novo Nordisk Foundation injects €736M in European biotech
Joachim Eeckhout, +1
Jan 15, 2026
Caldera raised $112M to target IBD & Cyprium's Menkes disease drug get approved
Joachim Eeckhout, +1
Jan 13, 2026
AbbVie kicks off JPM26 with a $5.6B deal & Novartis bets $1.7B brain-shuttle tech
Joachim Eeckhout, +1
Jan 12, 2026
Aktis starts 2026 with a $318M IPO & Aurora raises $16M for CRISPR-gene editing
Joachim Eeckhout, +1
Jan 09, 2026
Lily buys Ventyx for $1.2B & Epibiologics raises $107M for its protein degraders
Joachim Eeckhout, +1
Jan 08, 2026
Amgen taps into Disco Pharma's pipeline & GSK/Ionis have a 'functional cure' for hepatitis B
Joachim Eeckhout, +1
Jan 07, 2026
Amgen buys Dark Blue's protein degraders & Alumis' psoriasis pill shows big promise
Joachim Eeckhout, +1
Jan 06, 2026
Zenas drug trial success fails to impress Wall Street, shares crash 55%
Joachim Eeckhout, +1
Jan 05, 2026
The first new motion sickness drug since 1979 & Genmab's pipeline update
Joachim Eeckhout, +1
First
Back
1
2
3
4
5
6
7
8
Next
Last
